| CTRV Shares Outstanding History Table | ||||||||||||||
Below is a table of the CTRV shares outstanding history going back to 5/29/2018:
Also see: CTRV Market Cap History CTRV YTD Return |
CTRV Shares Outstanding History — Contravir Pharmaceuticals Share Count Over Time
As of 6/3/2019 Contravir Pharmaceuticals has 590500 CTRV shares outstanding. Investors often track the CTRV shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CTRV share count trends over time, with 6 historical shares outstanding datapoints presented, dating back to 5/29/2018.
| CTRV Shares Outstanding History Chart | |||||||||||||||
CTRV Historical Shares Outstanding: +279.97% CAGR 
Mouse over chart for data details
| |||||||||||||||
| CTRV Stock Price Chart |
| About Hepion Pharmaceuticals Inc |
| Hepion Pharmaceuticals is a biopharmaceutical company focused primarily on the clinical development and commercialization of targeted antiviral therapies with a specific focus on developing a potentially curative therapy for hepatitis B virus (HBV). Co. is developing two anti-HBV compounds with complementary mechanisms of action. Co.'s key compound, TXL™ is in development and is designed to deliver high intrahepatic concentrations of tenofovir (TFV), while minimizing off-target effects caused by high levels of circulating TFV. CRV431, Co.'s second compound for HBV, is a next-generation cyclophilin inhibitor with a structure that increases its selective index against TXL™. We show 6 historical shares outstanding datapoints in our coverage of CTRV's shares outstanding history. Understanding the changing numbers of CTRV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CTRV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CTRV by allowing them to research CTRV shares outstanding history as well as any other stock in our coverage universe. |
| CTRV Current Stock Quote |
Quotes delayed 20 minutes  Free CTRV Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CTRV Share Performance |
| Shares Outstanding Peers |
| Contravir Pharmaceuticals (CTRV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CTSO Shares Outstanding History CTXR Shares Outstanding History CUE Shares Outstanding History CUR Shares Outstanding History CUTR Shares Outstanding History CVKD Shares Outstanding History CVRX Shares Outstanding History CVS Shares Outstanding History CWBR Shares Outstanding History CYCC Shares Outstanding History More Healthcare companies » |
CTRV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
